Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (716)	11/25/2002 11:30:10 AM
From: Biomaven	Read Replies (1) \| Respond to of 3559

Miljenko, Doesn't they have priority* for fresh results and/or real time consulting arrangement with investigators?* In my view most "analysts" are primarily concerned with getting the quarterly loss forecast accurate. Very few actually go out and do much research themselves, and unfortunately it's mostly the short-oriented outfits that do the work. Leerink Swan generally does a good job of going out and collecting views from doctors, but I don't believe they cover REGN. Peter